TextSearch

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.

Investment IdeasMy PortfolioHow It WorksLog InSign UpGilead Sciences, Inc.StocksBiotechnologyConsumer, Non-cyclicalMedium riskSign UpSign inThe Exchange works from 13:30 to 19:50 on your time zoneChange for the year23.05%Current Price-Capitalization78.37 bln. $FeesEnter and leave fee is 0.5%, but not less than 0.50 $About investment ideaGilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.What Are the Benefits of Investing with United Traders?No minimum thresholdThe minimum amount of participation in an investment is the value of one stock.Profit from the difference in quotes and dividendsYou get profit from the difference in quotes and additional profit if the company pays dividends.ConvenientTo open an account, you do not have to go to the bank - we open an investment account online. To buy stocks, you do not need to install and configure a trading platform.Low comissionEnter and leave fee is 0.5%, but not less than 0.50 $Tracking resultsYou can see the result of the investment in your account on your computer or smartphone. The profit chart is updated in real time. The graph has the number of stocks and the exact value of the asset, here you will see a transaction report.We do not limit the investment period - you can close the deal at any time. However, the longer the investment period, the higher the probability of making money, therefore we do not recommend emotionally responding to possible price fluctuations.Key investment terms and conditionsRights and obligationsThe investment conditions and obligations of UT are governed by the offer. This document specifies all legal issues.Exchange HoursAll applications are executed during the operation of the exchange (New York, UTC − 5: 00). An application sent before the market opens is executed in the first minutes of the exchange.Purchase conditionsThe investor makes a profit due to the difference in the value of assets and current shares, but does not own shares.Miscellaneous termsThe price of a real purchase of shares may differ from the exchange price due to the volatility and liquidity of a particular share.RisksThis is Stocks and ETF investment idea. Analytical department United Traders did not check its potential profitability and risks. You can find the analyzed ideas in the section Best Ideas.Invest in Gilead Sciences, Inc.Sign UpSign inThe Exchange works from 13:30 to 19:50 on your time zoneContact via TelegramContact via WhatsAppwelcome@unitedtraders.comInvestmentsPartnershipTradingContactsYouTubeTwitterTelegramRisk statementsPrivacy policyMobile version of the siteENGРусскийEnglishEspañol

Invest in Gilead Sciences, Inc. | United Traders